Cytokines in inflammatory bowel disease

Area of Science:

• Immunology
• Gastroenterology
• Molecular Biology

Background:

• Cytokines are key mediators in the pathogenesis of inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis.
• An imbalance between pro-inflammatory and anti-inflammatory cytokines is characteristic of IBD, hindering inflammation resolution and promoting tissue destruction.
• Emerging evidence points to a regulatory cytokine network influencing IBD progression.

Purpose of the Study:

• To review the critical role of cytokines in IBD pathogenesis.
• To discuss cytokines produced by both innate and adaptive immune cells in the context of IBD.
• To explore the therapeutic implications of cytokine modulation for future IBD treatment.

Main Methods:

• Literature review of recent studies on cytokines in IBD.
• Analysis of cytokine networks and their impact on disease progression.
• Synthesis of information on immune cell-derived cytokines relevant to IBD.

Main Results:

• Cytokines orchestrate inflammatory responses in IBD.
• Dysregulation of cytokine balance is central to IBD perpetuation.
• Specific cytokine profiles are associated with disease progression and severity.

Conclusions:

• Cytokines are critical targets for understanding and treating IBD.
• Targeting cytokine networks offers promising therapeutic strategies for IBD.
• Further research into immune cell-derived cytokines can advance IBD management.